Home › Sunovion Pharmaceuticals Inc. And Afraxis, Inc. Announce Novel Drug Discovery Partnership
 

Keywords :   


Sunovion Pharmaceuticals Inc. And Afraxis, Inc. Announce Novel Drug Discovery Partnership

2013-09-04 07:19:53| drugdiscoveryonline News Articles

Sunovion Pharmaceuticals Inc. (Sunovion) and Afraxis, Inc. recently announced that they have signed a partnership agreement to utilize the unique Enhanced Spine Platform (ESP) developed by Afraxis, Inc. to accelerate Sunovion’s preclinical central nervous system (CNS) drug discovery process

Tags: drug partnership discovery announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Update Statement
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Forecast Discussion Number 8
07.10Hurricane Milton Graphics
07.10Farm Progress America, October 7, 2024
07.10Farm Progress America, October 7, 2024
07.10Hurricane Milton Storm Surge Watch/Warning Map
More »